EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY-NC-ND 4.0

Postpartum hemorrhage after SARS ‐ CoV ‐2 infection in pregnancy: A Scandinavian register‐based cohort study

Trine Damsted Rasmussen iD, Stine Kjaer Urhoj iD, Maria C Magnus, Jonas Söderling, Laura L Oakley iD, Anne K Örtqvist iD, Hellen M Edwards, Lone Krebs, Hilde M Engjom, Olof Stephansson iD, Siri E Håberg, Anne-Marie Nybo Andersen und 1 weitere

Acta Obstetricia et Gynecologica Scandinavica · 2025

DOI: 10.1111/aogs.70069 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Acta Obstetricia et Gynecologica Scandinavica, 2025. Verfasst von Trine Damsted Rasmussen und 12 weiteren Autor:innen. Beteiligte Einrichtung: Section of Epidemiology, Department of Public Health, University of Copenhagen, Copenhagen, Denmark. Hauptthemen laut MEDLINE: Postpartum Hemorrhage, COVID-19, Pregnancy Complications, Infectious. Die Arbeit nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NordForsk, Norges Forskningsråd.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

The aim was to evaluate whether SARS‐CoV‐2 infection during pregnancy was associated with severe postpartum hemorrhage (PPH), as SARS‐CoV‐2 infection has been shown to affect the coagulation system. Material and Methods In this national register‐based cohort study in Sweden, Denmark, and Norway, we studied the association between severe PPH according to a registered positive test for SARS‐CoV‐2 during pregnancy between March 1, 2020 and March 31, 2023 using logistic regression analyses to estimate odds ratios (ORs) with 95% confidence intervals (CI). Country‐specific estimates of association were combined in random effects meta‐analyses. The primary outcome was severe PPH, defined as a blood loss >1500 mL and/or receiving a blood transfusion.

Results

We included 542 394 singleton deliveries (264 804 in Sweden, 143 775 in Denmark, and 133 815 in Norway), of which 62 606 women (11%) had a positive SARS‐CoV‐2 test during pregnancy, and 20 786 (3.8%) deliveries were registered with a severe PPH. Overall, we observed no association between testing positive for SARS‐CoV‐2 during pregnancy and severe PPH (combined adjusted OR 1.04; 95% CI: 0.96–1.12). The results were similar for different calendar periods corresponding to dominant SARS‐CoV‐2 variants. We did, however, observe an association between severe PPH and women testing positive within 7 days before delivery (combined adjusted OR 1.30; 95% CI: 1.10–1.53).

Conclusions

There was no association identified between SARS‐CoV‐2 test positivity and PPH of >1500 mL and/or blood transfusion in pregnant women from three Scandinavian countries. However, we observed a 30% higher odds of severe PPH among pregnant women who tested positive within one week before delivery.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Postpartum HemorrhageCOVID-19Pregnancy Complications, InfectiousHumansFemalePregnancyRegistriesAdultCohort StudiesNorwayScandinavian and Nordic CountriesSwedenSARS-CoV-2DenmarkBlood Transfusion

Stichwörter der Autor:innen

COVID‐19SARS‐CoV‐2bleedingpostpartum hemorrhagepregnancy

Autor:innen und Institutionen

  • Section of Epidemiology, Department of Public Health, University of Copenhagen, Copenhagen, Denmark.
  • Statistics Denmark, Copenhagen, Denmark.
  • Centre for Fertility and Health, Norwegian Institute of Public Health, Oslo, Norway.
  • Clinical Epidemiology Division, Department of Medicine, Solna, Karolinska Institutet, Stockholm, Sweden.
  • Department of Non-Communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK.
  • Department of Obstetrics and Gynecology, Visby County Hospital, Visby, Sweden.

ORCID-Profile: Trine Damsted Rasmussen, Stine Kjaer Urhoj, Laura L Oakley, Anne K Örtqvist, Olof Stephansson

Förderung

  • NordForsk
  • Norges Forskningsråd

Zitieren

APA

Rasmussen, T. D., Urhoj, S. K., Magnus, M. C., Söderling, J., Oakley, L. L., Örtqvist, A. K., Edwards, H. M., Krebs, L., Engjom, H. M., Stephansson, O., Håberg, S. E., Andersen, A. N., & Aabakke, A. J. M. (2025). Postpartum hemorrhage after SARS ‐ CoV ‐2 infection in pregnancy: A Scandinavian register‐based cohort study. Acta Obstetricia et Gynecologica Scandinavica. https://doi.org/10.1111/aogs.70069

Vancouver

Rasmussen TD, Urhoj SK, Magnus MC, Söderling J, Oakley LL, Örtqvist AK, et al. Postpartum hemorrhage after SARS ‐ CoV ‐2 infection in pregnancy: A Scandinavian register‐based cohort study. Acta Obstetricia et Gynecologica Scandinavica. 2025. doi:10.1111/aogs.70069

BibTeX
@article{Rasmussen2025,
  author = {Rasmussen, Trine Damsted and Urhoj, Stine Kjaer and Magnus, Maria C and Söderling, Jonas and Oakley, Laura L and Örtqvist, Anne K and Edwards, Hellen M and Krebs, Lone and Engjom, Hilde M and Stephansson, Olof and Håberg, Siri E and Andersen, Anne-Marie Nybo and Aabakke, Anna J M},
  title = {Postpartum hemorrhage after SARS ‐ CoV ‐2 infection in pregnancy: A Scandinavian register‐based cohort study},
  journal = {Acta Obstetricia et Gynecologica Scandinavica},
  year = {2025},
  doi = {10.1111/aogs.70069}
}
Kostenlos starten →